Infectious Disease Diagnostics Market: By Product Type (Assays, Kits, & Reagents, Instruments, Services & Software), By Testing Type (Laboratory Testing, POC Testing), By Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, Others), By Disease Type (COVID-19, HIV, HAIs, Hepatitis, STDs, HPV, TB, Influenza, Others), By End User (Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, Others) and Geography

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Infectious Disease Diagnostics market was valued at USD 14,007.8 million in 2022 and is poised to grow at a CAGR of 4.4% over 2023-2029. A diagnostic is a laboratory test used to diagnose infectious illnesses with the assistance of trained technicians and clinicians. It is a diagnostic method that involves identifying and characterizing the infectious disease's causing organism. Various diagnostic procedures and devices are used to test a sample of urine, blood, mucus, or other bodily fluids to determine the causing organism. Based on the disease type HIV/AIDS is anticipated to show a significant growth rate in the market share over the forecasting period. According to the Minority of HIV/AIDS Fund (MHAF), United States Department of Health and Human Services Statistics, revised in June 2021, there were an estimated 37.6 million individuals living with HIV Diagnostics in the globe in 2020, including 35.9 million adults and 1.7 million children (under 15 years old). Moreover, the company are focusing in launching new products to maintain growth in the market In March 2021, Roche Diagnostics Launched Cobas SARS-CoV-2 Variant Set 1 Test to help monitor emerging coronavirus mutations. The growing prevalence of infectious diseases, greater understanding of the diagnosis increases in government funding, rising healthcare costs, and increasing adoption of technologically advanced diagnostic equipment in healthcare organizations also heighten the overall growth of the market.

Infectious Disease Diagnostics Market Recent Key Developments:

In February 2021, Thermo Fisher Scientific acquired Mesa Biotech (US) to expand the benefits of molecular diagnostics at the point of care.

In March 2020, Abbott Laboratories launched the ID NOW COVID-19 Test.

Global Infectious Disease Diagnostics Market Summary

Study Period

2023-29

Base Year

2022

CAGR

4.4%

Largest Market

North America

Fastest Growing Market

Canada
Infectious Disease Diagnostics Market Dynamics

The market is expected to rise as the number of medical laboratories practicing infectious disease diagnostic tests have been increased. Increased prevalence of infectious diseases such as hepatitis, influenza, COVID-19, and HIV; increased demand for infection diagnostic tests; increased funding from private and government organizations for diagnostic service centers; and advancements in infectious disease diagnostic technologies. Have also anticipated grow the market in the forecasting period. Moreover, In order to improve COVID-19 testing capacity, the Indian government announced the opening of three state-of-the-art high throughput Indian Council of Medical Research laboratories in Kolkata, Mumbai, and Noida in 2020.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Infectious Disease Diagnostics Market Segmentation

By Product Type
  • Instruments
  • Software
  • Assays & Reagents
By Disease Type
  • HIV, Hepatitis
  • Tuberculosis
  • Human papillomavirus infection
  • Influenza A&B
  • Sexually Transmitted Diseases
  • and Others
By Technology
  • Immunodiagnostics
  • Clinical Microbiology
  • Polymerase Chain Reaction
  • Next Generation Sequencing
  • Others
By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Frequently Asked Questions

The infectious disease diagnostics market is projected to expand at a CAGR of 4.4% during the forecast period.

Abbott Laboratories, Becton Dickinson and Company, bioMerieus SA, Bio-Rad Laboratories, Danaher Corporation, F Hoffman-La Roche

North America is the fastest-growing region for infectious disease diagnostics market

The development and launch of point-of-care diagnostic instruments and kits is a key opportunity for companies to enhance their revenue. over the forecast years

Increase in the adoption of molecular diagnostic test kits such as PCR kits for accurate results compared with other diagnostic techniques is a major trend in the infectious disease diagnosis market.

1. Executive Summary
2. Global Infectious Disease Diagnostics Market Introduction
2.1. Global Infectious Disease Diagnostics Market – Taxonomy
2.2. Global Infectious Disease Diagnostics Market –Definitions
2.2.1. Product Type
2.2.2. Testing Type
2.2.3. Technology
2.2.4. Disease Type
2.2.5. End User
3. Global Infectious Disease Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Infectious Disease Diagnostics Market Dynamic Factors - Impact Analysis
3.6. Global Infectious Disease Diagnostics Market – Competition Landscape
4. Global Infectious Disease Diagnostics Market Analysis,2017 - 2021 and Forecast, 2022 - 2028
4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Infectious Disease Diagnostics Market, By Product Type, 2017–2021and Forecast, 2022–2028 (Revenue, USD Mn)
5.1. Assays, Kits, & Reagents
5.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Instruments
5.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Services & Software
5.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Infectious Disease Diagnostics Market, By Testing Type, 2017 – 2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
6.1. Laboratory Testing
6.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. POC Testing
6.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Infectious Disease Diagnostics Market Forecast, By Technology,2017–2021and Forecast, 2022–2028 (Revenue, USD Mn)
7.1. Immunodiagnostics
7.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Clinical Microbiology
7.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. PCR
7.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. INAAT
7.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. DNA Sequencing & NGS
7.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Others
7.6.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
8. Global Infectious Disease Diagnostics Market Forecast, By Disease Type, 2017 – 2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
8.1. COVID-19
8.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. HIV
8.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. HAIs
8.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Hepatitis
8.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. STDs
8.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. HPV
8.6.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
8.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.6.3. Market Opportunity Analysis
8.7. TB
8.7.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
8.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.7.3. Market Opportunity Analysis
8.8. Influenza
8.8.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
8.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.8.3. Market Opportunity Analysis
8.9. Others
8.9.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
8.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.9.3. Market Opportunity Analysis
9. Global Infectious Disease Diagnostics Market, By End User, 2017 – 2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
9.1. Diagnostic Laboratories
9.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Hospitals & Clinics
9.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Academic Research Institutes
9.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Others
9.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
10. Global Infectious Disease Diagnostics Market Forecast, By Region, 2017–2021and Forecast, 2022–2028(Revenue, USD Mn)
10.1. North America
10.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.1.3. Market Opportunity Analysis
10.2. Europe
10.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.2.3. Market Opportunity Analysis
10.3. Asia-Pacific
10.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.3.3. Market Opportunity Analysis
10.4. Latin America
10.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.4.3. Market Opportunity Analysis
10.5. Middle East and Africa
10.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.5.3. Market Opportunity Analysis
10.6. Global Infectious Disease Diagnostics Market - Opportunity Analysis Index, By Product Type, Testing Type, Technology, Disease Type, End User and Region, 2022 - 2028
11. North America Infectious Disease Diagnostics MarketAnalysis,2017–2021and Forecast, 2022–2028(Revenue, USD Mn)
11.1. Product Type Analysis 2017–2021and Forecast 2022 - 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Assays, Kits, & Reagents
11.1.2. Instruments
11.1.3. Services & Software
11.2. Testing Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Laboratory Testing
11.2.2. POC Testing
11.3. Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Immunodiagnostics
11.3.2. Clinical Microbiology
11.3.3. PCR
11.3.4. INAAT
11.3.5. DNA Sequencing & NGS
11.3.6. Others
11.4. Disease Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. COVID-19
11.4.2. HIV
11.4.3. HAIs
11.4.4. Hepatitis
11.4.5. STDs
11.4.6. HPV
11.4.7. TB
11.4.8. Influenza
11.4.9. Others
11.5. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.5.1. Diagnostic Laboratories
11.5.2. Hospitals & Clinics
11.5.3. Academic Research Institutes
11.5.4. Others
11.6. Country Analysis 2017 - 2021 and Forecast 2022 - 2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.6.1. USA
11.6.2. Canada
11.7. North America Infectious Disease Diagnostics Market - Opportunity Analysis Index, By Product Type, Testing Type, Technology, Disease Type, End User and Country, 2022 - 2028
11.8. North America Infectious Disease Diagnostics Market Dynamics – Trends
12. Europe Infectious Disease Diagnostics Market Analysis, 2017–2021and Forecast, 2022–2028(Revenue, USD Mn)
12.1. Product Type Analysis 2017–2021and Forecast 2022 - 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Assays, Kits, & Reagents
12.1.2. Instruments
12.1.3. Services & Software
12.2. Testing Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Laboratory Testing
12.2.2. POC Testing
12.3. Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Immunodiagnostics
12.3.2. Clinical Microbiology
12.3.3. PCR
12.3.4. INAAT
12.3.5. DNA Sequencing & NGS
12.3.6. Others
12.4. Disease Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. COVID-19
12.4.2. HIV
12.4.3. HAIs
12.4.4. Hepatitis
12.4.5. STDs
12.4.6. HPV
12.4.7. TB
12.4.8. Influenza
12.4.9. Others
12.5. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.5.1. Diagnostic Laboratories
12.5.2. Hospitals & Clinics
12.5.3. Academic Research Institutes
12.5.4. Others
12.6. Country Analysis 2017–2021and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.6.1. Germany
12.6.2. UK
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Russia
12.6.7. Poland
12.6.8. Rest of Europe
12.7. Europe Infectious Disease Diagnostics Market - Opportunity Analysis Index, By Product Type, Testing Type, Technology, Disease Type, End Userand Country, 2022 - 2028
12.8. Europe Infectious Disease Diagnostics Market Dynamics – Trends
13. Asia-Pacific Infectious Disease Diagnostics Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
13.1. Product Type Analysis 2017–2021and Forecast 2022 - 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
13.1.1. Assays, Kits, & Reagents
13.1.2. Instruments
13.1.3. Services & Software
13.2. Testing Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Laboratory Testing
13.2.2. POC Testing
13.3. Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Immunodiagnostics
13.3.2. Clinical Microbiology
13.3.3. PCR
13.3.4. INAAT
13.3.5. DNA Sequencing & NGS
13.3.6. Others
13.4. Disease Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. COVID-19
13.4.2. HIV
13.4.3. HAIs
13.4.4. Hepatitis
13.4.5. STDs
13.4.6. HPV
13.4.7. TB
13.4.8. Influenza
13.4.9. Others
13.5. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.5.1. Diagnostic Laboratories
13.5.2. Hospitals & Clinics
13.5.3. Academic Research Institutes
13.5.4. Others
13.6. Country Analysis2017–2021and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.6.1. Japan
13.6.2. China
13.6.3. India
13.6.4. ASEAN
13.6.5. Australia & New Zealand
13.6.6. Rest of Asia-Pacific
13.7. Asia-Pacific Infectious Disease Diagnostics Market - Opportunity Analysis Index, By Product Type, Testing Type, Technology, Disease Type, End User and Country,2022 - 2028
13.8. Asia-Pacific Infectious Disease Diagnostics Market Dynamics – Trends
14. Latin America Infectious Disease Diagnostics Market Analysis,2017 - 2021 and Forecast, 2022–2028(Revenue, USD Mn)
14.1. Product Type Analysis 2017–2021and Forecast 2022 - 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
14.1.1. Assays, Kits, & Reagents
14.1.2. Instruments
14.1.3. Services & Software
14.2. Testing Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Laboratory Testing
14.2.2. POC Testing
14.3. Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Immunodiagnostics
14.3.2. Clinical Microbiology
14.3.3. PCR
14.3.4. INAAT
14.3.5. DNA Sequencing & NGS
14.3.6. Others
14.4. Disease Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. COVID-19
14.4.2. HIV
14.4.3. HAIs
14.4.4. Hepatitis
14.4.5. STDs
14.4.6. HPV
14.4.7. TB
14.4.8. Influenza
14.4.9. Others
14.5. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.5.1. Diagnostic Laboratories
14.5.2. Hospitals & Clinics
14.5.3. Academic Research Institutes
14.5.4. Others
14.6. Country Analysis 2017–2021and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Argentina
14.6.4. Rest of Latin America
14.7. Latin America Infectious Disease Diagnostics Market - Opportunity Analysis Index, By Product Type, Testing Type, Technology, Disease Type, End User and Country, 2022 - 2028
14.8. Latin America Infectious Disease Diagnostics Market Dynamics – Trends
15. Middle East and Africa Infectious Disease Diagnostics Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
15.1. Product Type Analysis 2017–2021and Forecast 2022 - 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
15.1.1. Assays, Kits, & Reagents
15.1.2. Instruments
15.1.3. Services & Software
15.2. Testing Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.2.1. Laboratory Testing
15.2.2. POC Testing
15.3. Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.3.1. Immunodiagnostics
15.3.2. Clinical Microbiology
15.3.3. PCR
15.3.4. INAAT
15.3.5. DNA Sequencing & NGS
15.3.6. Others
15.4. Disease Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.4.1. COVID-19
15.4.2. HIV
15.4.3. HAIs
15.4.4. Hepatitis
15.4.5. STDs
15.4.6. HPV
15.4.7. TB
15.4.8. Influenza
15.4.9. Others
15.5. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.5.1. Diagnostic Laboratories
15.5.2. Hospitals & Clinics
15.5.3. Academic Research Institutes
15.5.4. Others
15.6. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
15.6.1. Gulf Cooperation Council (GCC) Countries
15.6.2. Israel
15.6.3. South Africa
15.6.4. Rest of MEA
15.7. MEA Infectious Disease Diagnostics Market - Opportunity Analysis Index, By Product Type, Testing Type, Technology, Disease Type, End User and Country, 2022 - 2028
15.8. MEA Infectious Disease Diagnostics Market Dynamics – Trends
16. Competition Landscape 
16.1. Strategic Dashboard of Top Market Players
16.2. Company Profiles (Introduction, Financial Analysis, Product Type& Service Testing Types, Key Developments, Strategies, and SWOT Analysis)
16.2.1. Abbott Laboratories
16.2.2. Becton Dickinson and Company
16.2.3. bioMerieus SA
16.2.4. Bio-Rad Laboratories
16.2.5. Danaher Corporation
16.2.6. F Hoffman-La Roche
16.2.7. Hologic Inc.
16.2.8. Luminex Corporation
16.2.9. Qiagen Inc.
16.2.10. Thermo Fisher Scientific Inc.
16.2.11. LumiraDx
17. Research Methodology
18. Key Assumptions and Acronyms
  • Abbott Laboratories
  • Becton Dickinson and Company
  • BioMerieus SA
  • Bio-Rad Laboratories
  • Danaher Corporation
  • F Hoffman-La Roche
  • Hologic Inc.
  • Luminex Corporation
  • Qiagen Inc
  • Thermo Fisher Scientific Inc.
  • LumiraDx